Clinical Research Directory
Browse clinical research sites, groups, and studies.
Defining Response Criteria for PET Scans for People With Neuroendocrine Tumors
Sponsor: Memorial Sloan Kettering Cancer Center
Summary
People with neuroendocrine cancer typically have imaging scans before and after treatment, including positron emission tomography (PET) scans. The scans are analyzed using a set of criteria that describes how the disease has responded to treatment. The purpose of this study is to establish new criteria for doctors to use when evaluating these PET scans. Researchers are testing whether these new criteria are useful for predicting whether a person's cancer gets better, gets worse, or stays the same. Researchers will also compare these new criteria to the current standard criteria for evaluating imaging scans.
Official title: Definition of PET REsponSe CrItEria for Neuroendocrine Tumors (PRESCIENT)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
11
Start Date
2024-06-03
Completion Date
2026-06
Last Updated
2026-03-09
Healthy Volunteers
No
Conditions
Interventions
positron emission tomography (PET) scans
Before and after treatment.
Locations (1)
Memorial Sloan Kettering Cancer Center
New York, New York, United States